Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 162.21M | 40.27M | 10.28M | 6.42M | 287.16M |
Gross Profit | 67.82M | 19.72M | 5.27M | -220.00K | 135.22M |
EBITDA | 13.94M | 1.48M | -16.44M | -25.62M | -12.58M |
Net Income | 9.03M | -2.20M | -17.92M | -32.89M | -45.31M |
Balance Sheet | |||||
Total Assets | 153.22M | 105.36M | 89.99M | 112.62M | 198.93M |
Cash, Cash Equivalents and Short-Term Investments | 85.17M | 85.16M | 75.86M | 95.87M | 45.75M |
Total Debt | 14.68M | 7.49M | 9.61M | 14.41M | 26.96M |
Total Liabilities | 84.46M | 45.77M | 28.83M | 34.16M | 87.90M |
Stockholders Equity | 68.59M | 59.42M | 60.98M | 78.28M | 110.85M |
Cash Flow | |||||
Free Cash Flow | 24.25M | 16.43M | -9.84M | -41.50M | -64.93M |
Operating Cash Flow | 27.65M | 18.61M | -6.94M | -40.61M | -63.05M |
Investing Cash Flow | -21.61M | -22.66M | 19.94M | 79.84M | 29.70M |
Financing Cash Flow | -7.78M | -4.89M | -8.46M | -18.60M | -35.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | HK$79.03M | 23.48 | 5.77% | 4.52% | 139.07% | 193.94% | |
71 Outperform | HK$345.70M | 7.29 | 6.61% | 5.56% | -3.59% | 4.81% | |
71 Outperform | HK$51.84B | 20.76 | 11.72% | 0.81% | 34.16% | 40.10% | |
57 Neutral | HK$25.53B | 4.08 | -2.03% | 6.84% | -0.31% | -67.64% | |
45 Neutral | HK$334.71M | ― | ― | -34.67% | -99.72% | ||
42 Neutral | HK$101.04B | ― | -4.92% | ― | 7.08% | ― | |
40 Underperform | $1.17B | ― | -118.67% | ― | -50.72% | 14.86% |